Cognition Therapeutics, Inc. (CGTX) Misses Q1 EPS by 2c

Cognition Therapeutics, Inc. (NASDAQ: CGTX) reported Q1 EPS of ($0.27), $0.02 worse than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Cognition Therapeutics, Inc. (CGTX) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown